Capecitabine
Hepatic Steatosis
Yuen Kah HaySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Hepatic Steatosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Wellbutrin Carmen Dietvorst | Phase 4 | BB |
AMINO ACIDS,ESSENTIAL University of Colorado, Denver | Phase 3 | B |
Byetta University of Colorado, Denver | Phase 2/3 | B |
Chazhu Xiaozhi Decoction Shanghai Municipal Hospital of Traditional Chinese Medicine | Phase 2 | B |
Tocotrienol-Rich Fraction Vitamin E Yuen Kah Hay | Phase 2 | B |
View all 10 →
Same molecule, other indications
Capecitabine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →